Expanded Access
Expanded access is a way for patients with serious diseases or conditions who cannot participate in a clinical study to gain access to a medical product that has not been approved by the Food and Drug Administration.
Expanded access is a way for patients with serious diseases or conditions who cannot participate in a clinical study to gain access to a medical product that has not been approved by the Food and Drug Administration.
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.
